nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—Inactivation, recovery and regulation of the phototransduction cascade—PPEF1—hematologic cancer	0.103	0.168	CbGpPWpGaD
Nitroxoline—METAP2—The phototransduction cascade—PPEF1—hematologic cancer	0.101	0.164	CbGpPWpGaD
Nitroxoline—METAP2—hematopoietic system—hematologic cancer	0.0845	0.218	CbGeAlD
Nitroxoline—METAP2—gonad—hematologic cancer	0.0642	0.166	CbGeAlD
Nitroxoline—METAP2—blood—hematologic cancer	0.056	0.144	CbGeAlD
Nitroxoline—METAP2—bone marrow—hematologic cancer	0.0542	0.14	CbGeAlD
Nitroxoline—METAP2—lung—hematologic cancer	0.0491	0.127	CbGeAlD
Nitroxoline—METAP2—testis—hematologic cancer	0.0463	0.119	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—PPEF1—hematologic cancer	0.0431	0.0705	CbGpPWpGaD
Nitroxoline—METAP2—lymph node—hematologic cancer	0.0336	0.0865	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—AGRN—hematologic cancer	0.0243	0.0397	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—SDC1—hematologic cancer	0.0148	0.0242	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LYZ—hematologic cancer	0.00672	0.011	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PPEF1—hematologic cancer	0.00548	0.00895	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CHMP5—hematologic cancer	0.00479	0.00782	CbGpPWpGaD
Nitroxoline—METAP2—Disease—B3GAT1—hematologic cancer	0.00479	0.00782	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RHOJ—hematologic cancer	0.00471	0.00769	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HDAC11—hematologic cancer	0.00433	0.00708	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IFT172—hematologic cancer	0.00419	0.00685	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LIG4—hematologic cancer	0.00415	0.00678	CbGpPWpGaD
Nitroxoline—METAP2—Disease—BCR—hematologic cancer	0.00415	0.00678	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PSIP1—hematologic cancer	0.004	0.00653	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PC—hematologic cancer	0.004	0.00653	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HDAC10—hematologic cancer	0.00386	0.00631	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SLC35B2—hematologic cancer	0.00386	0.00631	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PPEF1—hematologic cancer	0.00384	0.00627	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPLP1—hematologic cancer	0.00309	0.00504	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AGRN—hematologic cancer	0.00309	0.00504	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SNCA—hematologic cancer	0.00309	0.00504	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HDAC11—hematologic cancer	0.00303	0.00495	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LEF1—hematologic cancer	0.00298	0.00486	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HMMR—hematologic cancer	0.00293	0.00478	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BCR—hematologic cancer	0.00291	0.00475	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ELL—hematologic cancer	0.00275	0.00449	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HDAC10—hematologic cancer	0.0027	0.00442	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ACP5—hematologic cancer	0.00268	0.00437	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NCOR2—hematologic cancer	0.00264	0.00431	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IDH1—hematologic cancer	0.00252	0.00411	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GSTO1—hematologic cancer	0.00249	0.00406	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ARHGEF12—hematologic cancer	0.00247	0.00404	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AGO2—hematologic cancer	0.00243	0.00398	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ARHGEF1—hematologic cancer	0.00241	0.00394	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HDAC9—hematologic cancer	0.00241	0.00394	CbGpPWpGaD
Nitroxoline—METAP2—Disease—H3F3B—hematologic cancer	0.00238	0.0039	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NPM1—hematologic cancer	0.0023	0.00375	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF19—hematologic cancer	0.0022	0.00359	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS14—hematologic cancer	0.00218	0.00356	CbGpPWpGaD
Nitroxoline—METAP2—Disease—DKK1—hematologic cancer	0.00216	0.00354	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AGRN—hematologic cancer	0.00216	0.00353	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL17—hematologic cancer	0.00216	0.00353	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT5B—hematologic cancer	0.00215	0.00351	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NUP98—hematologic cancer	0.00215	0.00351	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCR5—hematologic cancer	0.00212	0.00347	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CST3—hematologic cancer	0.0021	0.00343	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ADCY7—hematologic cancer	0.00208	0.00341	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LEF1—hematologic cancer	0.00208	0.0034	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NUP214—hematologic cancer	0.00207	0.00338	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GNA13—hematologic cancer	0.00205	0.00335	CbGpPWpGaD
Nitroxoline—METAP2—Disease—XIAP—hematologic cancer	0.00203	0.00331	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTR—hematologic cancer	0.00203	0.00331	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TIAM1—hematologic cancer	0.00202	0.00329	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ENO2—hematologic cancer	0.00199	0.00325	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SMARCA4—hematologic cancer	0.00198	0.00323	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JAK3—hematologic cancer	0.00195	0.00319	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SDC1—hematologic cancer	0.00189	0.00308	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR7—hematologic cancer	0.00187	0.00306	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL13—hematologic cancer	0.00187	0.00306	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NCOR2—hematologic cancer	0.00185	0.00302	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CRKL—hematologic cancer	0.00183	0.00298	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL3RA—hematologic cancer	0.00183	0.00298	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LCK—hematologic cancer	0.00183	0.00298	CbGpPWpGaD
Nitroxoline—METAP2—Disease—H3F3A—hematologic cancer	0.00179	0.00292	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RGS2—hematologic cancer	0.00176	0.00288	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TRIO—hematologic cancer	0.00174	0.00285	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TRH—hematologic cancer	0.00174	0.00285	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CMA1—hematologic cancer	0.00174	0.00285	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRKCZ—hematologic cancer	0.00174	0.00284	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CALR—hematologic cancer	0.00171	0.00279	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SPHK1—hematologic cancer	0.0017	0.00278	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AGO2—hematologic cancer	0.0017	0.00278	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HDAC9—hematologic cancer	0.00169	0.00276	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LPAR1—hematologic cancer	0.00169	0.00276	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PARP1—hematologic cancer	0.00168	0.00274	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—H3F3B—hematologic cancer	0.00167	0.00273	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FBXW7—hematologic cancer	0.00165	0.0027	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HDAC2—hematologic cancer	0.00162	0.00265	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CXCR4—hematologic cancer	0.00162	0.00265	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD44—hematologic cancer	0.0016	0.00262	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CBL—hematologic cancer	0.00158	0.00258	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CNR2—hematologic cancer	0.00155	0.00254	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDE4B—hematologic cancer	0.00155	0.00254	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF19—hematologic cancer	0.00154	0.00252	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RAC2—hematologic cancer	0.00153	0.0025	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DKK1—hematologic cancer	0.00152	0.00248	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HSP90AA1—hematologic cancer	0.00151	0.00246	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT5B—hematologic cancer	0.0015	0.00246	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADCY7—hematologic cancer	0.00146	0.00238	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT1—hematologic cancer	0.00145	0.00237	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—XIAP—hematologic cancer	0.00142	0.00232	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SH2B3—hematologic cancer	0.00138	0.00226	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SMARCA4—hematologic cancer	0.00138	0.00226	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GZMB—hematologic cancer	0.00138	0.00225	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GRB2—hematologic cancer	0.00136	0.00222	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PDGFA—hematologic cancer	0.00136	0.00222	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CTNNA1—hematologic cancer	0.00134	0.00219	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KITLG—hematologic cancer	0.00134	0.00218	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EIF4EBP1—hematologic cancer	0.00134	0.00218	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HSPB1—hematologic cancer	0.00134	0.00218	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL3—hematologic cancer	0.00134	0.00218	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTHLH—hematologic cancer	0.00132	0.00216	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SDC1—hematologic cancer	0.00132	0.00216	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT5A—hematologic cancer	0.00131	0.00213	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN2B—hematologic cancer	0.0013	0.00212	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTGER4—hematologic cancer	0.00129	0.0021	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LCK—hematologic cancer	0.00128	0.00209	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—H3F3A—hematologic cancer	0.00125	0.00205	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD86—hematologic cancer	0.00125	0.00205	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HES1—hematologic cancer	0.00124	0.00202	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NCOR1—hematologic cancer	0.00123	0.00201	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCZ—hematologic cancer	0.00122	0.00199	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF1—hematologic cancer	0.00121	0.00198	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FOXO1—hematologic cancer	0.0012	0.00196	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PDGFRB—hematologic cancer	0.0012	0.00195	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PARP1—hematologic cancer	0.00118	0.00192	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PDGFRA—hematologic cancer	0.00118	0.00192	CbGpPWpGaD
Nitroxoline—METAP2—Disease—JAK1—hematologic cancer	0.00117	0.00192	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRKCG—hematologic cancer	0.00117	0.00192	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FBXW7—hematologic cancer	0.00116	0.00189	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCR4—hematologic cancer	0.00114	0.00185	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HDAC2—hematologic cancer	0.00114	0.00185	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CBL—hematologic cancer	0.00111	0.00181	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL3—hematologic cancer	0.00109	0.00179	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTHFR—hematologic cancer	0.00109	0.00177	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HLA-A—hematologic cancer	0.00108	0.00177	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TERT—hematologic cancer	0.00108	0.00177	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTPN1—hematologic cancer	0.00108	0.00176	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RASGRP1—hematologic cancer	0.00106	0.00173	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PDGFB—hematologic cancer	0.00106	0.00173	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SYK—hematologic cancer	0.00106	0.00172	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HSP90AA1—hematologic cancer	0.00106	0.00172	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TSC2—hematologic cancer	0.00103	0.00169	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT1—hematologic cancer	0.00102	0.00166	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGFR3—hematologic cancer	0.000994	0.00162	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRB2—hematologic cancer	0.000952	0.00156	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDGFA—hematologic cancer	0.00095	0.00155	CbGpPWpGaD
Nitroxoline—METAP2—Disease—BAD—hematologic cancer	0.000942	0.00154	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KITLG—hematologic cancer	0.000936	0.00153	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOTCH1—hematologic cancer	0.000933	0.00152	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT5A—hematologic cancer	0.000915	0.00149	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD80—hematologic cancer	0.000914	0.00149	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KIT—hematologic cancer	0.000912	0.00149	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN2B—hematologic cancer	0.000907	0.00148	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTPN11—hematologic cancer	0.000896	0.00146	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CD86—hematologic cancer	0.000877	0.00143	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CREB1—hematologic cancer	0.000868	0.00142	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HES1—hematologic cancer	0.000865	0.00141	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NCOR1—hematologic cancer	0.00086	0.00141	CbGpPWpGaD
Nitroxoline—METAP2—Disease—BRAF—hematologic cancer	0.000857	0.0014	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CSF2—hematologic cancer	0.000851	0.00139	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF1—hematologic cancer	0.000851	0.00139	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6R—hematologic cancer	0.000847	0.00138	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CREBBP—hematologic cancer	0.000846	0.00138	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FOXO1—hematologic cancer	0.000838	0.00137	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDGFRB—hematologic cancer	0.000837	0.00137	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDGFRA—hematologic cancer	0.000824	0.00135	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCG—hematologic cancer	0.000821	0.00134	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JAK1—hematologic cancer	0.000821	0.00134	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAP2K1—hematologic cancer	0.000807	0.00132	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CD—hematologic cancer	0.000802	0.00131	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF2—hematologic cancer	0.000768	0.00125	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL2RA—hematologic cancer	0.000767	0.00125	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TERT—hematologic cancer	0.000758	0.00124	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3R1—hematologic cancer	0.000757	0.00124	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDGFB—hematologic cancer	0.00074	0.00121	CbGpPWpGaD
Nitroxoline—METAP2—Disease—JAK2—hematologic cancer	0.000736	0.0012	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TSC2—hematologic cancer	0.000723	0.00118	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MDM2—hematologic cancer	0.000718	0.00117	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CB—hematologic cancer	0.000699	0.00114	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTOR—hematologic cancer	0.000699	0.00114	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD4—hematologic cancer	0.000698	0.00114	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGFR3—hematologic cancer	0.000696	0.00114	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK14—hematologic cancer	0.000689	0.00113	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ESR1—hematologic cancer	0.000676	0.0011	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FN1—hematologic cancer	0.000668	0.00109	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BAD—hematologic cancer	0.00066	0.00108	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NFKBIA—hematologic cancer	0.00066	0.00108	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN1B—hematologic cancer	0.000656	0.00107	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH1—hematologic cancer	0.000653	0.00107	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CD80—hematologic cancer	0.00064	0.00105	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CG—hematologic cancer	0.000639	0.00104	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KIT—hematologic cancer	0.000639	0.00104	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTPN11—hematologic cancer	0.000628	0.00103	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CREB1—hematologic cancer	0.000608	0.000993	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN1A—hematologic cancer	0.000605	0.000989	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTEN—hematologic cancer	0.000604	0.000987	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BRAF—hematologic cancer	0.0006	0.000981	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL2—hematologic cancer	0.000595	0.000972	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6R—hematologic cancer	0.000593	0.000969	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CREBBP—hematologic cancer	0.000592	0.000968	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EP300—hematologic cancer	0.000576	0.000941	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAP2K1—hematologic cancer	0.000565	0.000923	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CD—hematologic cancer	0.000562	0.000917	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SRC—hematologic cancer	0.00056	0.000915	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT3—hematologic cancer	0.00054	0.000882	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NRAS—hematologic cancer	0.000539	0.00088	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF2—hematologic cancer	0.000538	0.000878	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3R1—hematologic cancer	0.00053	0.000866	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAPK3—hematologic cancer	0.000516	0.000843	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JAK2—hematologic cancer	0.000515	0.000842	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MDM2—hematologic cancer	0.000503	0.000822	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MYC—hematologic cancer	0.000502	0.00082	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TGFB1—hematologic cancer	0.000501	0.000818	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MTOR—hematologic cancer	0.000489	0.0008	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CB—hematologic cancer	0.000489	0.0008	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KRAS—hematologic cancer	0.000464	0.000758	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN1B—hematologic cancer	0.000459	0.00075	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CASP3—hematologic cancer	0.00045	0.000735	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL2—hematologic cancer	0.00045	0.000734	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCND1—hematologic cancer	0.000438	0.000716	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JUN—hematologic cancer	0.000437	0.000714	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CA—hematologic cancer	0.000426	0.000696	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN1A—hematologic cancer	0.000424	0.000693	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTEN—hematologic cancer	0.000423	0.000691	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK8—hematologic cancer	0.000414	0.000676	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EP300—hematologic cancer	0.000403	0.000659	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HRAS—hematologic cancer	0.000394	0.000644	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SRC—hematologic cancer	0.000392	0.000641	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFA—hematologic cancer	0.000382	0.000624	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT3—hematologic cancer	0.000378	0.000618	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NRAS—hematologic cancer	0.000377	0.000616	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6—hematologic cancer	0.000377	0.000616	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK3—hematologic cancer	0.000361	0.00059	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MYC—hematologic cancer	0.000352	0.000574	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TGFB1—hematologic cancer	0.000351	0.000573	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT1—hematologic cancer	0.000348	0.000569	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KRAS—hematologic cancer	0.000325	0.000531	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CA—hematologic cancer	0.000298	0.000487	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TP53—hematologic cancer	0.000289	0.000472	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HRAS—hematologic cancer	0.000276	0.000451	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6—hematologic cancer	0.000264	0.000432	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT1—hematologic cancer	0.000244	0.000398	CbGpPWpGaD
